Last week the Third Circuit became the first federal appellate court to decide the question of whether federal courts have jurisdiction over COVID-related tort litigation. It concluded they did not. Maglioli v. Alliance HC Holdings LLC, — F.4th –, 2021 WL 4890189 (3d. Cir. Oct. 20, 2021). A decision directly at odds with
Truthful Statements Cannot Form Basis for Consumer Fraud Claims
This post is from the non-Reed Smith side of the blog.
One would assume the title of this post to be a given. Afterall, the crux of a fraud claim is that the consumer was deceived or misled in some way. Therefore, truthful and accurate statements should not be grounds for consumer fraud claims. But
New York Rejects General Jurisdiction by Consent to Service
Today’s decision strays from the field of prescription drug/device law, but we take this detour because Aybar v. Aybar, 2021 N.Y. LEXIS 2134 (N.Y. Ct. App. Oct. 7, 2021) is an important jurisdictional decision – one with over 100 years of legal precedent to sort out.
Plaintiffs were involved in an automobile accident in
Georgia Statute of Repose Knocks Out Failure to Warn Case
We aren’t going to beat around the bush today – the facts of Paulsen v. Abbott Laboratories, 2021 WL 4439408 (N.D. Ill. Sept. 28, 2021) are straightforward and so too will we be. This case is largely about the chronology, so here it is:
- Plaintiff gets injections of the drug in February and March
Plaintiff Inches Out Summary Judgment Win on Design Defect
It’s football season! That means beautiful fall weather, tailgating, pots of chili, rooting your favorite team to victory, and wallowing in their losses. It’s Army v. Navy and Ohio State v. Michigan. It’s Packers v. Bears and Steelers v. Ravens. If you are a true fan of the game, it doesn’t matter that in a
California Court Agrees with Circuits That Agree with Snap Removal
We looked back over the blog and it’s been over one year since we posted on snap removal. Last spring and summer, we reported on new pre-service removals almost monthly. So, we decided to poke around a bit and see if there was anything going on outside the drug and device law space. We found
Just a Few Words on Off-Label Use
Sometimes our weekly searches for what is going on in the drug and device world lead as outside the traditional products liability context that is our bread and butter. Occasionally that can be refreshing – a break from preemption and causation and TwIqbal. It’s also interesting to see how things like off-label use come
Another Birmingham Hip Case Bites the Dust
After getting off to a rocky start a few years ago on preemption, cases in the Birmingham hip MDL are falling like dominoes. And just like last week’s case, the decision in Sedgwick v. Smith & Nephew, Inc., 2021 U.S. Dist. LEXIS 157412 (D. Md. Aug. 19, 2021) falls apart at the summary
Causation Prevails to Garner Defendants a Summary Judgment Win in Birmingham Hip MDL
This blog is no stranger to the In re Smith & Nephew Birmingham HIP Resurfacing (BBR) HIP Implant Products Liability Litigation, MDL 2775, pending in the District of Maryland. Nor have we hidden our disregard for several of its decisions, going back to its preemption ruling on defendant’s motion to dismiss which made our
Defendant Won Summary Judgment the Old-Fashioned Way
If you are one of our readers who fall into the over 50 demographic, we are going to assume that in your head you read the title of today’s post in John Houseman’s voice and you tagged it with “they earned it.” That’s because you were alive in the early 1980s when if you wanted